SPC generics waiver comes into force
vepar5 / Shutterstock.com
The European Union has adopted the proposed supplementary protection certificate (SPC) manufacturing waiver, despite criticism from parts of the pharmaceutical industry.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
European Union, European Council, supplementary protection certificate, generics, biosimilar